Aandeel PRISMMEDI6 PRISM MEDICO AND PHARMACY LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Prism Medico and Pharmacy Limited

Aandelen

PRISMMEDI6

INE730E01016

Beurs gesloten - Bombay S.E.
Andere beurzen
 12:00:51 15-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
23,61 INR +5,78% Intraday-grafiek van Prism Medico and Pharmacy Limited +0,38% -22,64%
13/02 Prism Medico and Pharmacy Limited rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 31 december 2023 CI
2023 Prism Medico and Pharmacy Limited rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 30 september 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Prism Medico and Pharmacy : Submission of confirmation certificate as per Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2024.
Prism Medico and Pharmacy Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Prism Medico and Pharmacy Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Prism Medico and Pharmacy Limited Approves to Regularize the Appointment of Dinesh Kumar as A Director (Non-Executive, Independent Director)
Prism Medico and Pharmacy Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Prism Medico and Pharmacy Limited Announces the Appointment of Mr. Vishwambhar Dayal Gupta as Director
Prism Medico and Pharmacy Limited Appoints Sakshi Laller as A Whole Time Director (Promoter, Executive Director, Women Director)
Prism Medico Appoints CFO
Prism Medico's CFO Resigns
Symbiosis Pharmaceutical Services Limited, Galaxy Vitacare Private Limited, and Ramit Walia completed the acquisition of a 1.07% stake in Prism Medico and Pharmacy Limited for INR 0.71 million
Symbiosis Pharmaceutical Services Limited, Galaxy Vitacare Private Limited and Ramit Walia made an offer to acquire a 26% stake in Prism Medico and Pharmacy Limited from its shareholders for INR 17.34 million
Galaxy Vitacare Private Limited, Symbiosis Pharmaceutical Services Limited and Ramit Walia entered a share purchase agreement to acquire a 23.93% stake in Prism Medico and Pharmacy Limited from Ajooni Biotech Limited, Parmjeet Kaur, Jasjot Singh and Charanjit Singh Bhatia for INR 15.96 million.
Prism Medico and Pharmacy Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Prism Medico and Pharmacy : Disclosure U/R 74(5) Of SEBI (DP) Regulations 2018
Prism Medico and Pharmacy Widens Net Loss in Fiscal Q1; Shares Drop 3%
Prism Medico and Pharmacy Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Prism Medico and Pharmacy : Financial Results Updates
Prism Medico and Pharmacy : Disclosure U/R 32 Of SEBI (LODR) Reg 2015
Prism Medico and Pharmacy : Disc UR 31(4) / 31(5) Of SAST Regulations 2011
Prism Medico and Pharmacy Limited Announces Address Changes
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers PRISMMEDI6
  4. Nieuws Prism Medico and Pharmacy Limited
  5. Andere talen